INOVIO to Report Second Quarter 2025 Financial Results on August 12, 2025
INOVIO (NASDAQ:INO), a biotechnology company specializing in DNA medicines for HPV-associated diseases, cancers, and infectious diseases, will release its Q2 2025 financial results on August 12, 2025 after market close.
The company will host a conference call and webcast at 4:30 p.m. ET the same day, featuring a general business update and analyst Q&A session. Investors can access the live webcast through INOVIO's investor relations website, with a replay available for 90 days post-event.
INOVIO (NASDAQ:INO), un'azienda biotecnologica specializzata in farmaci a base di DNA per malattie associate a HPV, tumori e malattie infettive, pubblicher脿 i suoi risultati finanziari del secondo trimestre 2025 il 12 agosto 2025 dopo la chiusura del mercato.
Lo stesso giorno, la societ脿 terr脿 una call e webcast alle 16:30 ET, con un aggiornamento generale sul business e una sessione di domande e risposte con gli analisti. Gli investitori potranno seguire la diretta streaming tramite il sito web delle relazioni con gli investitori di INOVIO, con la possibilit脿 di rivedere la registrazione per 90 giorni dopo l'evento.
INOVIO (NASDAQ:INO), una empresa biotecnol贸gica especializada en medicamentos de ADN para enfermedades asociadas al VPH, c谩nceres y enfermedades infecciosas, publicar谩 sus resultados financieros del segundo trimestre de 2025 el 12 de agosto de 2025 despu茅s del cierre del mercado.
La compa帽铆a realizar谩 una conferencia telef贸nica y webcast a las 4:30 p.m. ET el mismo d铆a, con una actualizaci贸n general del negocio y una sesi贸n de preguntas y respuestas para analistas. Los inversores podr谩n acceder a la transmisi贸n en vivo a trav茅s del sitio web de relaciones con inversores de INOVIO, con una repetici贸n disponible durante 90 d铆as tras el evento.
INOVIO (NASDAQ:INO)電� HPV 甏�霠� 歆堩櫂, 鞎� 氚� 臧愳椉氤戩潉 鞙勴暅 DNA 鞚橃暯頀堨潉 鞝勲鞙茧 頃橂姅 靸濍獏瓿淀暀 須岇偓搿�, 2025雲� 8鞗� 12鞚� 鞁滌灔 毵堦皭 頉� 2025雲� 2攵勱赴 鞛 瓴瓣臣毳� 氚滍憸頃� 鞓堨爼鞛呺媹雼�.
須岇偓電� 臧欖潃 雮� 霃欕秬 鞁滉皠 鞓ろ泟 4鞁� 30攵勳棎 旎嵓霟办姢 旖� 氚� 鞗轨簮鞀ろ姼毳� 歆勴枆頃橂┌, 鞚茧皹 靷梾 鞐呺嵃鞚错姼鞕� 鞎犽剱毽姢韸� 歆堨潣鞚戨嫷 靹胳厴鞚� 韽暔霅╇媹雼�. 韴瀽鞛愲摛鞚� INOVIO 韴瀽鞛� 甏�瓿� 鞗轨偓鞚错姼毳� 韱淀暣 霛检澊敫� 鞗轨簮鞀ろ姼鞐� 鞝戩啀頃� 靾� 鞛堨溂氅�, 鞚措菠韸� 膦呺 頉� 90鞚� 霃欖晥 鞛嫓觳澊 臧�電ロ暕雼堧嫟.
INOVIO (NASDAQ:INO), une entreprise de biotechnologie sp茅cialis茅e dans les m茅dicaments 脿 base d'ADN pour les maladies associ茅es au HPV, les cancers et les maladies infectieuses, publiera ses r茅sultats financiers du deuxi猫me trimestre 2025 le 12 ao没t 2025 apr猫s la cl么ture du march茅.
La soci茅t茅 organisera le m锚me jour une conf茅rence t茅l茅phonique et un webcast 脿 16h30 ET, comprenant une mise 脿 jour g茅n茅rale des activit茅s et une session de questions-r茅ponses avec les analystes. Les investisseurs pourront acc茅der au webcast en direct via le site des relations investisseurs d'INOVIO, avec une rediffusion disponible pendant 90 jours apr猫s l'茅v茅nement.
INOVIO (NASDAQ:INO), ein Biotechnologieunternehmen, das sich auf DNA-Medikamente f眉r HPV-assoziierte Krankheiten, Krebs und Infektionskrankheiten spezialisiert hat, wird seine Finanzergebnisse f眉r das zweite Quartal 2025 am 12. August 2025 nach B枚rsenschluss ver枚ffentlichen.
Das Unternehmen wird am selben Tag eine Telefonkonferenz und Webcast um 16:30 Uhr ET veranstalten, die ein allgemeines Gesch盲ftsupdate und eine Analysten-Fragerunde beinhaltet. Investoren k枚nnen den Live-Webcast 眉ber die Investor-Relations-Website von INOVIO verfolgen, eine Aufzeichnung ist 90 Tage nach der Veranstaltung verf眉gbar.
- None.
- None.
The live webcast will be available online at . This is a listen-only event but will include a live Q&A with analysts. The webcast will be archived and available for replay for 90 days following the event.
About INOVIO
INOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancers, and infectious diseases. INOVIO's technology optimizes the design and delivery of innovative DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit .
Contacts
Media: Jennie Willson, (267) 429-8567, [email protected]
Investors: Peter Vozzo - ICR Healthcare, (443) 213-0505,听[email protected]听
View original content to download multimedia:
SOURCE INOVIO Pharmaceuticals, Inc.
FAQ
When will INOVIO (NASDAQ:INO) release its Q2 2025 earnings?
What time is INOVIO's Q2 2025 earnings call?
How can investors access INOVIO's Q2 2025 earnings webcast?
How long will INOVIO's Q2 2025 earnings webcast be available for replay?
